clopidogrel and Aging

clopidogrel has been researched along with Aging in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (22.22)29.6817
2010's6 (66.67)24.3611
2020's1 (11.11)2.80

Authors

AuthorsStudies
Gevaert, SA; Sinnaeve, PR1
Alexander, KP; Armstrong, PW; Clemmensen, P; Fox, KA; Goodman, SG; Hochman, JS; Kaul, P; Ohman, EM; Prabhakaran, D; Roe, MT; Savu, A; White, HD1
Carriero, A; De Luca, G; Kedhi, E; Nardin, M; Pergolini, P; Rolla, R; Suryapranata, H; Tonon, F; Verdoia, M1
Dupouy, P; Labbe, R; Pernes, JM; Pongas, D; Rubimbura, V; Sotirov, I1
Horenstein, RB; Jiang, XL; Lesko, LJ; Lewis, JP; Peletier, LA; Samant, S; Schmidt, S; Shuldiner, AR1
Ariotti, S; Franzone, A; Gargiulo, G; Heg, D; Magnani, G; Marino, M; Piccolo, R; Santucci, A; Tebaldi, M; Valgimigli, M; Windecker, S1
Caruthers, RL; Dorsch, MP1
Alexy, T; Feher, G; Horvath, B; Kenyeres, P; Kesmarky, G; Koltai, K; Lenart, I; Marton, Z; Toth, K1
Bongard, V; CarriƩ, D; Lhermusier, T; SiƩ, P; Tidjane, MA; Voisin, S1

Trials

2 trial(s) available for clopidogrel and Aging

ArticleYear
Sex And Prognostic Significance of Self-Reported Frailty in Non-ST-Segment Elevation Acute Coronary Syndromes: Insights From the TRILOGY ACS Trial.
    The Canadian journal of cardiology, 2019, Volume: 35, Issue:4

    Topics: Acute Coronary Syndrome; Aged; Aging; Clopidogrel; Comorbidity; Exercise; Female; Frailty; Hand Strength; Humans; Male; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Prevalence; Prognosis; Self Report; Sex Factors; Walking Speed

2019
Ischaemic and bleeding outcomes in elderly patients undergoing a prolonged versus shortened duration of dual antiplatelet therapy after percutaneous coronary intervention: insights from the PRODIGY randomised trial.
    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2017, May-15, Volume: 13, Issue:1

    Topics: Age Factors; Aged; Aged, 80 and over; Aging; Aspirin; Clopidogrel; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Complications; Thrombosis; Ticlopidine

2017

Other Studies

7 other study(ies) available for clopidogrel and Aging

ArticleYear
Antiplatelet strategies in ageing patients with acute coronary syndromes.
    Lancet (London, England), 2020, 04-25, Volume: 395, Issue:10233

    Topics: Acute Coronary Syndrome; Aged; Aging; Clopidogrel; Humans; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Ticagrelor

2020
Impact of aging on platelet reactivity in diabetic patients receiving dual antiplatelet therapy.
    Journal of thrombosis and thrombolysis, 2019, Volume: 48, Issue:3

    Topics: Acute Coronary Syndrome; Age Factors; Aged; Aged, 80 and over; Aging; Aspirin; Clopidogrel; Diabetes Mellitus; Dual Anti-Platelet Therapy; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Activation; Platelet Aggregation Inhibitors; Risk Factors; Ticagrelor

2019
[A case review: About a STEMI in the very elderly].
    Annales de cardiologie et d'angeiologie, 2015, Volume: 64, Issue:6

    Topics: Aged, 80 and over; Aging; Angioplasty, Balloon, Coronary; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Clopidogrel; Drug Therapy, Combination; Female; Heparin; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Ticlopidine; Treatment Outcome

2015
Identifying clinically relevant sources of variability: The clopidogrel challenge.
    Clinical pharmacology and therapeutics, 2017, Volume: 101, Issue:2

    Topics: Adult; Age Factors; Aged; Aged, 80 and over; Aging; Body Mass Index; Clopidogrel; Computer Simulation; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Diabetes Mellitus; Dose-Response Relationship, Drug; Drug Interactions; Female; Gastrointestinal Absorption; Half-Life; Humans; Liver; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Obesity; Platelet Aggregation; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Socioeconomic Factors; Ticlopidine

2017
Letter by Caruthers and Dorsch regarding article, "Dosing of clopidogrel for platelet inhibition in infants and young children: primary results of the platelet inhibition in children on cLOpidogrel (PICOLO) trial".
    Circulation, 2008, Aug-12, Volume: 118, Issue:7

    Topics: Adolescent; Adult; Aging; Child; Child, Preschool; Clopidogrel; Cytochrome P-450 CYP3A; Dose-Response Relationship, Drug; Humans; Infant; Platelet Aggregation; Platelet Aggregation Inhibitors; Ticlopidine

2008
Relation of platelet aggregation and fibrinogen levels to advancing age in aspirin- and thienopyridine-treated patients.
    Clinical hemorheology and microcirculation, 2008, Volume: 40, Issue:4

    Topics: Aged; Aging; Aspirin; Clopidogrel; Cohort Studies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fibrinogen; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Ticlopidine

2008
More on: adenosine diphosphate-inducible platelet reactivity shows a pronounced age dependency in the initial phase of antiplatelet therapy with clopidogrel.
    Journal of thrombosis and haemostasis : JTH, 2011, Volume: 9, Issue:3

    Topics: Adenosine Diphosphate; Aged; Aged, 80 and over; Aging; Angioplasty, Balloon, Coronary; Clopidogrel; Female; Humans; Male; Platelet Activation; Platelet Aggregation Inhibitors; Prospective Studies; Ticlopidine; Time Factors

2011